Global Dermatologicals Market Statistics, Development and Growth 2021
Consumer fears and the uncertainty provoked by the outbreak of COVID-19 is expected to cause a surge in demand for dermatologicals in 2020. As consumers do not know how long COVID-19 will last – with some scientists suggesting the virus could be present for up to two years – many turned to panic buying, stockpiling large quantities of products that they don’t need in case they run out or need them in the coming months or years.
Euromonitor International's Dermatologicals in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table ofContent
KEY DATA FINDINGS
2020 IMPACT
Topical germicidals/antiseptics are the big
winners in 2020 as consumers stockpile to prepare for uncertain future
Laprophan retains leadership thanks to top
brands and wide range of products
Maphar set to lose value share due to product
withdrawal and decline in demand for Kenta
RECOVERY AND OPPORTUNITIES
COVID-19 will continue to drive growth in
category as consumers fear long-term effects
Dermatologicals to benefit from positive
macroeconomic trends
Parapharmacies and internet retailing continue
to eat into pharmacies’ share
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category:
Value 2015-2020
Table 2 Sales of Dermatologicals by Category: %
Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals:
% Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: %
Value 2017-2020
Table 5 LBN Brand Shares of Hair Loss
Treatments: % Value 2017-2020
Table 6 Forecast Sales of Dermatologicals by
Category: Value 2020-2025
Table 7 Forecast Sales of Dermatologicals by
Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods
and Medical Services: Value 2015-2020
Table 9 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 10 Sales of Consumer Health by Category:
Value 2015-2020
Table 11 Sales of Consumer Health by Category:
% Value Growth 2015-2020
Table 12 NBO Company Shares of Consumer Health:
% Value 2016-2020
…... continued
CONTACT
DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment